MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    eHealth – an Opportunity for personalized Care? – Healthcare Professionals’ Technology Acceptance in the Care of Parkinson’s Patients

    J. Stuempel, J. Hohn, V. Fleckenstein, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To examine how eHealth may improve personalized care for people with Parkinson's disease (PwPD) from the perspective of healthcare professionals (HCPs). Background: Parkinson's disease…
  • 2024 International Congress

    Is essential tremor-plus phenotype a prodromal phase of Parkinson’s disease ?

    A. Rekik, A. Mili, H. Slimene, K. Jemai, E. Jarrar, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

    Objective: To study the probability of conversion of essential tremor (ET) and ET-plus patients to Parkinson's disease (PD). Background: ET-plus syndrome represents a wide spectrum…
  • 2024 International Congress

    The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach

    AT. Cimmino, P. Sanginario, F. Musso, D. Genovese, A. de Biase, M. Petracca, F. Bove, C. Piano, FD. Tiziano, AR. Bentivoglio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

    Objective: Our study aimed to identify the genetic determinants and their prevalence in an Italian cohort of Parkinson’s disease (PD) patients. Background: Advances in genetics…
  • 2024 International Congress

    Utilizing a global network to study environmental factors relating to Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, L. Jones, B. Fiske, S. Jasaityte, H. Morris, A. Noyce (Lund, Sweden)

    Objective: To identify and collect data on non-genetic variables from individuals with and without Parkinson’s disease (PD) in the Global Parkinson’s Genetics Program (GP2, http://gp2.org/).…
  • 2024 International Congress

    Artificial intelligence: a potential predictor of GBA1-mutated genotype in Parkinson’s Disease patients?

    G. Di Rauso, A. Ghibellini, S. Grisanti, F. Cavallieri, V. Fioravanti, E. Monfrini, G. Toschi, G. Portaro, J. Rossi, R. Sabadini, L. Gherardini, C. Lucchi, G. Biagini, L. Bononi, M. Gabbrielli, A. Di Fonzo, F. Valzania (Reggio Emilia, Italy)

    Objective: To assess whether artificial intelligence could predict GBA1-mutated genotype in Parkinson’s Disease (GBA1-PD) patients according to the different impact of significant clinical features. Background:…
  • 2024 International Congress

    Frequency of Variants of Uncertain Significance in a Cohort of Early-onset Parkinson’s Disease Patients

    A. Zare Dehnavi, C. Piat, N. Niu, O. Ross, A. de Menezes, P. Gaia, R. Savica (Rochester, USA)

    Objective: Aim of the study is to report the frequency of variants of uncertain significance (VUS) in a cohort of patients with early-onset Parkinson’s disease…
  • 2024 International Congress

    Fatigue in PD is related to decreased efficiency of the frontal network

    SY. Kang, MS. Kim, S. Park, U. Park, SW. Kang (Hwaseong, Republic of Korea)

    Objective: We aimed to explore whether electroencephalography (EEG) could measure fatigue objectively and the pathophysiology of fatigue in PD. Background: Fatigue is a common, frustrating…
  • 2024 International Congress

    Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease

    T. Fitzgerald, C. O'Keeffe, J. Inocentes, E. Murphy, M. Bradley, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The objective of this study was to determine the most relevant biomechanical factors contributing to the risk of falling in those with Parkinson’s Disease…
  • 2024 International Congress

    Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To determine if neuropsychiatric and axial motor symptoms at baseline would be predictive of freezing of gait (FoG) at 5-year follow up in participants…
  • 2024 International Congress

    Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort

    O. Ben Othman, S. Frikha, S. Fezai, A. Achouri, M. Ben Mahmoud, H. Jamoussi, S. Fray, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: We aim to study the relationship between clinical features in patients with Parkinson’s disease (PD)  and their IL-6 and IL-1β serum levels. Background: According…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley